Rafferty Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-158,931
| Closed | -$9.34M | – | 1106 |
|
|
2023
Q4 | $9.34M | Sell |
158,931
-90,681
| -36% | -$5.33M | 0.04% | 298 |
|
|
2023
Q3 | $10.9M | Buy |
249,612
+30,973
| +14% | +$1.35M | 0.06% | 206 |
|
|
2023
Q2 | $7.9M | Buy |
218,639
+45,123
| +26% | +$1.63M | 0.04% | 285 |
|
|
2023
Q1 | $6.45M | Sell |
173,516
-19,557
| -10% | -$727K | 0.04% | 319 |
|
|
2022
Q4 | $8.75M | Buy |
193,073
+111,361
| +136% | +$5.05M | 0.07% | 223 |
|
|
2022
Q3 | $5.71M | Buy |
81,712
+17,048
| +26% | +$1.19M | 0.06% | 310 |
|
|
2022
Q2 | $4.34M | Sell |
64,664
-1,537
| -2% | -$103K | 0.04% | 306 |
|
|
2022
Q1 | $5.44M | Buy |
66,201
+27,070
| +69% | +$2.23M | 0.03% | 370 |
|
|
2021
Q4 | $5.74M | Buy |
39,131
+20,312
| +108% | +$2.98M | 0.03% | 325 |
|
|
2021
Q3 | $3.33M | Buy |
18,819
+3,658
| +24% | +$647K | 0.02% | 422 |
|
|
2021
Q2 | $2.45M | Sell |
15,161
-2,374
| -14% | -$383K | 0.02% | 617 |
|
|
2021
Q1 | $3M | Buy |
17,535
+13,623
| +348% | +$2.33M | 0.02% | 493 |
|
|
2020
Q4 | $859K | Sell |
3,912
-11,109
| -74% | -$2.44M | 0.01% | 544 |
|
|
2020
Q3 | $2.49M | Buy |
15,021
+5,700
| +61% | +$946K | 0.03% | 356 |
|
|
2020
Q2 | $1.06M | Buy |
9,321
+5,207
| +127% | +$594K | 0.02% | 526 |
|
|
2020
Q1 | $316K | Sell |
4,114
-30,837
| -88% | -$2.37M | 0.01% | 423 |
|
|
2019
Q4 | $4.5M | Sell |
34,951
-40,816
| -54% | -$5.26M | 0.07% | 145 |
|
|
2019
Q3 | $5.9M | Buy |
75,767
+23,314
| +44% | +$1.82M | 0.09% | 129 |
|
|
2019
Q2 | $5.4M | Sell |
52,453
-19,043
| -27% | -$1.96M | 0.1% | 145 |
|
|
2019
Q1 | $5.24M | Buy |
+71,496
| New | +$5.24M | 0.08% | 131 |
|